書誌事項
- タイトル別名
-
- Post-extraction wound healing failure with long-term bone exposure related to sunitinib, a molecularly targeted drug
- ブンシ ヒョウテキヤク デ アル スニチニブ ノ カンヨ ガ ウタガワレタ チョウキカンコツ ロシュツ オ テイシタ バッシカチユ フゼン ノ 1レイ
この論文をさがす
抄録
Sunitinib, a multitargeted tyrosine kinase inhibitor that inhibits angiogenesis, improves progressionfree survival in advanced renal cell carcinoma, gastrointestinal stromal tumor, and pancreatic neuroendocrine tumor. Sunitinib triggers wound healing failure and osteonecrosis of the jaw because it inhibits not only angiogenesis, but also the functions of osteoblasts and osteoclasts. A 51-year-old man with a diagnosis of intraabdominal gastrointestinal stromal tumor was treated with sunitinib. He had his teeth extracted from the right and left sides of the upper jaw by a dental practitioner on the first day of the second cycle of sunitinib. He was referred to our hospital because of bone exposure in the sockets 26 days after teeth extraction. Examination revealed bone exposure in the right and left sides of the upper jaw. The patient had had no history of bisphosphonate or radiation therapy. During continuous treatment with sunitinib, he was followed up with washing the sockets and the mouth. The sockets were epithelialized within 105 days after teeth extraction. Our findings suggest that patients treated with sunitinib should be closely observed for wound healing failure after surgical treatment.
収録刊行物
-
- 日本口腔外科学会雑誌
-
日本口腔外科学会雑誌 60 (8), 494-498, 2014
社団法人 日本口腔外科学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001206531188992
-
- NII論文ID
- 130005087078
-
- NII書誌ID
- AN00189163
-
- ISSN
- 21861579
- 00215163
-
- NDL書誌ID
- 025777477
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可